sezione III civile; sentenza 4 gennaio 2010, n. 11; Pres. Morelli, Est. Chiarini, P.M. Russo (concl. conf.); Tota (Avv. Tota) c. Soc. Milano assicurazioni (Avv. Spinelli, Chiaia Noya). Conferma App. Bari 10 dicembre 2004

Publikováno v: Il Foro Italiano, 2010 Mar 01. 133(3), 851/852-855/856.

Externí odkaz: https://www.jstor.org/stable/23204273

Sezione III civile; sentenza 17 maggio 1966, n. 1263; Pres. Vallillo P., Est. Poggi, P. M. Raja (concl. conf.); Mastrolillo (Avv. Tota) c. Soc. ferrotramviaria (Avv. Milani)

Publikováno v: Il Foro Italiano, 1966 Jul 01. 89(7/8), 1243/1244-1247/1248.

Externí odkaz: https://www.jstor.org/stable/23155918

Identification of potential non-invasive biomarkers in diastrophic dysplasia.

Autor: Paganini C; Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Pavia, Italy., Carroll RS; Nemours Children's Hospital, Wilmington, DE, USA; Thomas Jefferson University, Philadelphia, PA, USA., Gramegna Tota C; Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Pavia, Italy., Schelhaas AJ; Nemours Children's Hospital, Wilmington, DE, USA., Leone A; Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Pavia, Italy; University School for Advanced Studies Pavia, IUSS Pavia, Pavia, Italy., Duker AL; Nemours Children's Hospital, Wilmington, DE, USA., O'Connell DA; Thomas Jefferson University, Philadelphia, PA, USA., Coghlan RF; Shriners Hospitals for Children, Portland, OR, USA., Johnstone B; Shriners Hospitals for Children, Portland, OR, USA; Oregon Health and Science University, Portland, OR, USA., Ferreira CR; National Human Genome Research Institute, NIH, Bethesda, MD, USA., Peressini S; Laboratory of Clinical Chemistry, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Albertini R; Laboratory of Clinical Chemistry, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Forlino A; Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Pavia, Italy., Bonafé L; Division of Genetic Medicine, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland., Campos-Xavier AB; Division of Genetic Medicine, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland., Superti-Furga A; Division of Genetic Medicine, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland., Zankl A; University of Sydney, The Children's Hospital at Westmead and Garvan Institute for Medical Research, Sydney, Australia., Rossi A; Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Pavia, Italy. Electronic address: antrossi@unipv.it., Bober MB; Nemours Children's Hospital, Wilmington, DE, USA; Thomas Jefferson University, Philadelphia, PA, USA.

Publikováno v: Bone [Bone] 2023 Oct; Vol. 175, pp. 116838. Date of Electronic Publication: 2023 Jul 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure. a real-world experience

Autor: Monzo, L, Gaudio, C, Cicogna, F, Tota, C, Petronilli, V, Mennuni, S, De Ruvo, E, Calò, L

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3686::34afdb22f439a7609095dce9e7c02582
http://hdl.handle.net/11573/1574666